Few point mutations have been described that specifically
inhibit the second step of group II intron splicing. Furthermore,
the effects of such mutations are typically not apparent
unless the mutations are studied in the context of a substrate
that harbors a very short 5′ exon. Truncation of
the 5′ exon slows the second step of splicing. Once
the second step has been slowed, the effects of point mutations
can be seen. We report the unexpected observation that
the deletion of a conserved GA dinucleotide dramatically
inhibits the second step of splicing, even when the mutation
is studied in the context of a full-length substrate. In
contrast, we find that this mutation does not significantly
affect the first step of splicing, unless the mutation
is studied in combination with a second point mutation
that is known to inhibit the first step. Even in that context,
the effect of the GA deletion mutation on the first step
is modest. These observations, together with the inferred
location of the GA dinucleotide in the three-dimensional
structure of the intron, suggest that this dinucleotide
plays a particularly important role in the second step
of splicing.